UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Discovers Major Genetic Risk Factor for the most Common Form of Glaucoma
SNP on chromosome 7 is rare among Chinese but confers five-fold increase in risk; underscores importance of analyzing risk factors across continental ancestries Reykjavik, ICELAND, 13 September 2010 – Scientists at deCODE genetics and academic colleagues from Iceland,...
deCODE Shows How Genetic Risk of Kidney Disease Frames Response to Environmental Risk over Time
A SNP on chromosome 16 appears to confer risk by affecting how the renal system adapts to the impact of aging and the onset of other common diseases Reykjavik, ICELAND, 29 July 2010 – Scientists at deCODE genetics and colleagues at Radboud University in the...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.